Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Financing channel feed
Pharvaris lands another $80M as it looks to tackle Takeda and CSL with an oral approach for HAE
5 years ago
MPM, DCVC Bio back $53M round for a bold concept: Let patients make their own CAR-T in vivo
5 years ago
Startups
Cell/Gene Tx
Elevation Oncology bags $65M to push failed Merrimack drug through PhII
5 years ago
Startups
Here's a $200M China startup idea — if you can read beyond the big words
5 years ago
Startups
China
With a 'monopoly' on glycoproteomics, InterVenn raises $34M to push cancer diagnostic into the clinic, woos Illumina BD exec
5 years ago
Doubling down on Sanofi's French roots, Paul Hudson infuses €50M into Jeito Capital to boost homegrown biotechs
5 years ago
Chasing a 'master modulator' in the endocannabinoid system, biotech upstart promises to shake up neuropsychiatric treatments
5 years ago
Startups
Kira Pharmaceuticals emerges from stealth with $46M and new CEO to lead complement therapy mission
5 years ago
Startups
Bayer fronts $65M Series A for Metagenomi, a gene therapy biotech aiming to find new CRISPR enzymes
5 years ago
Cell/Gene Tx
Silverback files to go public, potentially adding to this year's record-high biotech IPO raise
5 years ago
Small biotech Inipharm lands $35M to take new NASH approach, diverging from RNAi competitors
5 years ago
GV steps up to back Tillman Gerngross’ new antibody play against Covid-19 — and he’s already thinking about the IPO
5 years ago
Coronavirus
Prometheus Bio is ready for its close-up shot, following a $130M round to back IBD drugs now headed to the clinic
5 years ago
JW Therapeutics hauls in $300M IPO just as liso-cel-inspired CAR-T nears the finish line in China
5 years ago
China
Cell/Gene Tx
An ‘innocent bystander’ in the booming biotech investor world is writing a blank check for $100M. Who’s going to cash it?
5 years ago
Joe Jimenez has one more thing to do in biopharma. And now he and Mark Fishman have a $133M stake to play the startup game
5 years ago
Deals
Perceptive's third credit fund has $1.1B in 'incremental capital' for growing biotech and healthcare companies
5 years ago
Sean Bohen just wrote the handbook on how to make a quick fortune in biotech
5 years ago
People
Bioregnum
Two more biotechs price IPOs, bringing total raise to record heights
5 years ago
George Golumbeski and Faheem Hasnain team up with Vertex Ventures HC in managing $320M of biotech cash
5 years ago
People
Flagship launches Senda Biosciences with $88M in backing, looking to pioneer the field of 'Intersystems Biology'
5 years ago
Startups
Q32 Bio grabs $60M to kick off human studies for next-gen complement drugs — with some Covid-19 tweaks along the way
5 years ago
Perceptive recruits A-list investors to back its in-house China startup with a mammoth $310M raise
5 years ago
China
Eli Lilly partner TVM Capital raises $478M for their new life sciences fund, a 'substantial' oversubscription
5 years ago
First page
Previous page
87
88
89
90
91
92
93
Next page
Last page